NFE2L2 and central nervous system cancer: A gene expression profile analysis performed by using GEPIA2 (Gene Expression Profile Interactive Analysis 2) web server (Tang et al, 2019) highlighted increased NRF2 expression in GBM, low-grade glioma, pancreatic adenocarcinoma, and thymoma (Fig 1A).